CEGOLON, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 9.068
AS - Asia 8.209
EU - Europa 4.739
SA - Sud America 2.057
Continente sconosciuto - Info sul continente non disponibili 630
AF - Africa 357
OC - Oceania 106
Totale 25.166
Nazione #
US - Stati Uniti d'America 8.635
SG - Singapore 2.581
IT - Italia 1.656
BR - Brasile 1.583
CN - Cina 1.338
VN - Vietnam 982
HK - Hong Kong 880
KR - Corea 447
BD - Bangladesh 428
GB - Regno Unito 420
SE - Svezia 361
FR - Francia 341
DE - Germania 309
IN - India 274
BG - Bulgaria 247
PL - Polonia 241
RU - Federazione Russa 236
CA - Canada 202
NL - Olanda 194
IE - Irlanda 191
FI - Finlandia 181
IR - Iran 180
AR - Argentina 177
ID - Indonesia 132
JP - Giappone 98
IQ - Iraq 94
TH - Thailandia 94
AF - Afghanistan, Repubblica islamica di 93
TR - Turchia 92
AU - Australia 90
EC - Ecuador 87
AT - Austria 85
MX - Messico 85
ZA - Sudafrica 85
PK - Pakistan 80
CO - Colombia 76
CH - Svizzera 70
SA - Arabia Saudita 60
MY - Malesia 51
ES - Italia 47
ET - Etiopia 43
KE - Kenya 39
PH - Filippine 39
NG - Nigeria 38
EG - Egitto 37
MA - Marocco 36
PY - Paraguay 35
TW - Taiwan 35
JO - Giordania 32
CL - Cile 29
PE - Perù 28
TN - Tunisia 27
CR - Costa Rica 26
AE - Emirati Arabi Uniti 25
UA - Ucraina 25
UZ - Uzbekistan 25
VE - Venezuela 24
JM - Giamaica 22
IL - Israele 19
NP - Nepal 18
GR - Grecia 16
GT - Guatemala 15
TT - Trinidad e Tobago 15
NI - Nicaragua 14
NZ - Nuova Zelanda 14
AZ - Azerbaigian 13
HN - Honduras 13
OM - Oman 13
CZ - Repubblica Ceca 12
KZ - Kazakistan 12
BE - Belgio 11
MD - Moldavia 11
LB - Libano 10
PS - Palestinian Territory 10
UY - Uruguay 10
GH - Ghana 9
HR - Croazia 9
QA - Qatar 9
RO - Romania 9
SV - El Salvador 9
DK - Danimarca 8
HU - Ungheria 8
AL - Albania 7
BH - Bahrain 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
NO - Norvegia 7
SO - Somalia 7
LT - Lituania 6
TZ - Tanzania 6
BS - Bahamas 5
KW - Kuwait 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
AM - Armenia 4
DZ - Algeria 4
LK - Sri Lanka 4
PT - Portogallo 4
SI - Slovenia 4
Totale 24.454
Città #
Singapore 1.616
Ashburn 991
Hong Kong 829
San Jose 718
Council Bluffs 508
Seoul 399
Ho Chi Minh City 381
Beijing 314
Hefei 311
Santa Clara 289
Columbus 280
Chicago 275
Princeton 274
Trieste 241
Los Angeles 238
London 233
Sofia 213
Boardman 208
Hanoi 206
New York 190
Chandler 189
Zgierz 182
Milan 178
Lauterbourg 175
Dublin 155
Dallas 154
Buffalo 146
São Paulo 145
Moscow 123
Helsinki 122
The Dalles 119
Redmond 116
Phoenix 112
Wilmington 103
Rome 98
Des Moines 73
Atlanta 70
San Francisco 63
Frankfurt am Main 61
Orem 61
Rio de Janeiro 53
Vienna 53
Lappeenranta 52
Nuremberg 50
Seattle 50
Da Nang 49
Toronto 49
Houston 47
Kabul 45
Montreal 45
Bern 44
Tokyo 44
Denver 43
Warsaw 43
Tehran 41
Boydton 38
San Antonio 36
Haiphong 35
Nairobi 35
Melbourne 34
Shanghai 34
Addis Ababa 33
Munich 33
Phuket 33
Baghdad 31
Brooklyn 31
Cheyenne 31
Guangzhou 31
Turin 31
Guayaquil 30
Naples 30
Amman 29
Philadelphia 29
Quito 29
Chennai 28
Markovo 28
Riyadh 28
Curitiba 27
Dhaka 27
Lahore 27
Belo Horizonte 26
Johannesburg 26
Brasília 25
Campinas 25
Jakarta 25
Amsterdam 24
Bangkok 24
Bogotá 24
Hải Dương 24
Mexico City 23
Osaka 23
Porto Alegre 23
Miami 22
Miano 22
Tashkent 22
Boston 21
Lima 21
Limburg an der Lahn 21
Manchester 21
Redondo Beach 20
Totale 13.107
Nome #
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 840
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 806
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 547
HERV-K, vaccinazione per la febbre gialla e rischio di cancro 526
The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 498
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 425
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 312
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 310
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 304
Omalizumab chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response 278
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 277
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 270
Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial 242
Efficacy of ozone therapy on visual evoked potentials in diabetic patients 209
A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity—ORCHESTRA Project 189
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 188
Persistence of Symptoms 15 Months since COVID-19 Diagnosis: Prevalence, Risk Factors and Residual Work Ability 182
A rare case of empyema necessitatis sustained by Nocardia farcinica in a kidney transplant recipient 181
Concentration of mercury in human hair and associated factors in residents of the Gulf of Trieste (North-Eastern Italy) 170
Are “cases”, “waves”, “tests” and “modeling” deceiving indicators to describe the COVID-19 pandemic? 170
SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers. 168
SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020-7 February 2022: Occupational Risk and the Impact of the Omicron Variant 166
Seawater Pools Versus Freshwater Pools to Treat Inflammatory Skin Diseases and Rheumatic Conditions: A Scoping Review 162
Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life 157
A 6 months old infant with fever, dyspnea and poor feeding, diagnosed with COVID-19 157
Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents 157
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 156
Contrasting hair mercury in fishermen and workers of fish industry of Marano Lagunare (Upper Adriatic Sea), a coastal lagoon area contaminated by mining and industrial activities, against residents from the Dolomites Alps 156
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 155
Correction to: Concentration of mercury in human hair and associated factors in residents of the Gulf of Trieste (North‑Eastern Italy) 154
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 153
COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020–2 April 2022 148
Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review 148
Correction: Length of stay following vaginal deliveries: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015 148
Community use of face masks against the spread of covid-19 145
Determinants of length of stay after cesarean sections in the Friuli Venezia Giulia Region (North-Eastern Italy), 2005–2015 139
Predictors of failure to complete tuberculosis treatment in London, 2003-2006 138
Birth control knowledge among freshmen of four Italian universities 138
A Systematic Evaluation of Hospital Performance of Childbirth Delivery Modes and Associated Factors in the Friuli Venezia Giulia Region (North-Eastern Italy), 2005–2015 135
Chronic Kidney Disease Major Risk Factor for COVID-19 Severity and Mortality, A Scoping Review. 135
Determinants of Length of Stay After Vaginal Deliveries in the Friuli Venezia Giulia Region (North-Eastern Italy), 2005–2015 135
A Survey on Knowledge, Prevention, and Occurrence of Sexually Transmitted Infections among Freshmen from Four Italian Universities 135
Attitudes and Perceptions of health protection measures during the first wave of COVID-19 in Italy and Poland 134
Asbestos abatement workers versus asbestos workers:exposure and health effects differ 133
Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience 132
Occupational Risk Factors for SARS-CoV-2 Infection in Hospital Health Care Workers: A Prospective Nested Case-Control Study 132
Heart rate variability modulation through slow paced breathing in Healthcare workers with Long-COVID: a case-control study 130
A rare case of coexistence of Wegener’s granulomatosis and pulmonary tuberculosis with subsequent development of thrombosis of the cerebral veins 130
Length of Stay Following Vaginal Deliveries: A Population Based Study in the Friuli Venezia Giulia Region, North-Eastern Italy, 2005-2015 130
A Prospective Study on Risk Factors for Acute Kidney Injury and All-Cause Mortality in Hospitalized COVID-19 Patients From Tehran (Iran) 129
Nerve conduction assessment and magnetic resonance imaging for the diagnosis of localized hypertrophic neuropathy of the sciatic nerve and the lumbo-sacral plexus 128
SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020–31 January 2023 127
A Multi-Center Study on Sensitization to Thimerosal in North-Eastern Italy, 1997–2023: Prevalence, Risk Factors, the Role of Occupation and the Impact of Vaccinations 127
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 126
A European project on incidence, treatment, and outcome of sarcoma 126
Hypothiocyanite and hypothiocyanite/lactoferrin mixture exhibit virucidal activity in vitro against SARS-CoV-2 124
Asbestos-contacting floor tile and mastic: A Discussion of Exposure and Regulatory Issues 124
Allergic Reactions to COVID-19 Vaccination in High-Risk Allergic Patients: The Experience of Trieste University Hospital (North-Eastern Italy) 123
Artificial intelligence as a tool for enhancing the performance of public health emergency operation centres (EOC) 122
Iron deficiency anaemia and low BMI among adolescent girls in India: the transition from 2005 to 2015 121
Characteristics of adolescents who expressed indifference or no interest towards body art 118
Large saddle pulmonary embolism in a woman infected by COVID-19 pneumonia 118
Simultaneous Giant cavity pulmonary lesion and pneumothorax following COVID-19 pneumonia 118
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 117
National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis 116
A worksite intervention to reduce the cardiovascular risk: Proposal of a study design easy to integrate within Italian organization of occupational health surveillance 116
An Extremely Rare Case of Bilateral Sporadic Renal Hemangioblastoma 114
Safe abortion amid the COVID-19 pandemic: The case of Italy 113
Oncolytic Viruses: a novel treatment strategy for breast cancer 113
Length of stay following cesarean sections: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015 112
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 111
Body art in 4,277 Italian secondary school adolescents: prevalence and associations with personal and family characteristics 111
A 21-Year Perspective on Occupational Skin and Respiratory Diseases Among Food Handlers 110
Occupational exposure to mercury from cinnabar enriched sand in workers of Grado Beach, Gulf of Trieste (North-eastern Italy, upper Adriatic Sea) 110
Prevalence and Determinants of Sensitisation to Neomycinin North-Eastern Italy, 1997–2021 110
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 110
Determinants of Anti-S Immune Response at 9 Months after COVID-19 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project. 109
Antifibrotic therapeutic strategies in systemic sclerosis: Critical role of the Wnt/β-catenin and TGF-β signal transduction pathways as potential targets 109
A proposed threshold exposure for airborne asbestos 109
Body Art e Rischi Medico-Sanitari 109
Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria 108
The importance of event-based surveillance for preparedness and response in future respiratory pandemics 107
Rischi associati alla pratica ed alla rimozione dei tatuaggi 107
Training in occupational medicine: Jurisprudential malfunctions in the Italian system and European perspectives 106
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 105
Low immunoglobulin-E levels as potential biomarker to screen individuals susceptible to cancer in occupational settings 104
200 years from the first documented outbreak: Dying of cholera in the Near East during 2022 (recent data analysis) 104
The NCD/COVID-19 intimidating relationship: An urgent call for countries in the WHO Eastern Mediterranean Region 104
Sensitization to Disperse Blue Dye 124 in Triveneto Region from 1997 to 2021 and Its Potential Occupational Role 103
Understanding Factors Leading to Primary Cesarean Section and Vaginal Birth After Cesarean Delivery in the Friuli-Venezia Giulia Region (North-Eastern Italy), 2005–2015 103
The Italian national surveillance system for occupational injuries: conceptual framework and fatal outcomes, 2002–2016 103
Social determinants of health, Black race, sensitization to indoor molds and risk of severe asthma 102
Violence Against Healthcare: A Public Health Issue beyond Conflict Settings 102
Tuberculosis in schools: An outbreak in northeastern Italy and some key health protection interventions 102
Post-occupational health surveillance of asbestos workers 101
Early manifestation of ARDS in COVID-19 infection in a 51- year-old man affected by Mounier-Kuhn syndrome 101
Mental health and COVID-19 pandemics: The worrisome humanitarian perspective from the Middle East 101
Hypothesis to explain the severe form of COVID-19 in Northern Italy 101
Comment on: Early clinical manifestations of vibrio necrotising fasciitis 101
The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study 100
Totale 16.825
Categoria #
all - tutte 82.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.220 0 0 0 0 174 278 19 77 203 41 75 353
2022/20231.297 164 158 138 65 80 241 92 99 114 38 61 47
2023/20241.666 70 65 92 65 130 154 236 474 20 47 133 180
2024/20254.340 45 648 614 277 301 314 222 276 438 484 257 464
2025/202612.629 950 739 1.261 2.196 865 818 1.077 488 1.234 1.447 974 580
2026/20274.014 1.472 1.840 702 0 0 0 0 0 0 0 0 0
Totale 25.166